Product
Cam2020 M2SR H3N2 influenza vaccine
1 clinical trial
1 indication
Indication
InfluenzaClinical trial
Phase 1b Study to Investigate the Safety and Immunogenicity of Cam2020 (A/Cambodia/e0826360/2020) M2SR H3N2 Monovalent Influenza Vaccine Administered Alone or With Licensed, Inactivated Influenza Vaccine in Adults 65 to 85 Years OldStatus: Completed, Estimated PCD: 2022-11-03